Yves van Sante (Director)
Yves Van Sante (1960) studied Marketing, Communication and Commercial Management. He started his career in 1982 as an advisor at United Brokers and became sales manager for Brinkers International, the market leader in refining oil for the food industry, a year later. From 1987 until 1993 he served as Sales and Marketing manager Central Europe at 3C Communications in Luxemburg, where he launched Credit Card Telephony across Europe. Following this position, he became a business unit manager Public Telephony at Belgacom, the Belgium incumbent, where he managed a department of 650 employees and a € 40 million business. In 1994, together with Steven van der Velden, Yves co-founded InTouch Telecom. As its managing director he was responsible for business development, sales and marketing. In 1999, when achieving a turnover of € 25 million and having grown to 125 staff, InTouch was sold to GTS, a pan European Telecom operator. Yves became vice-president Business Services with GTS in London, where he consolidated acquisitions and turned the voice Telco around into an IP operator. In 2000 he became Managing Director of Eport, a call centre owned by the Port of Ostend. After six months Eport was sold to the Dutch call-centre Call-IT, and Yves became advisor to its Management Board. In 2002 Yves founded Q.A.T. Investments. Concurrently, he has held various Management and Board functions in companies in the QAT portfolio. He is a member of De Warande and member of the Board of Directors of Festival of Flanders. Yves lives in Belgium, is married and has a daughter. |
|
Roderick de Greef (Director)
Roderick de Greef (1961) has served on the Company's Board of Directors since January 2008. Mr. de Greef currently serves in various capacities for several life science companies, including Chairman of the Board of Directors of publicly traded Cambridge Heart, Inc., and Chief Financial Officer of Cardiopolymers, Inc., a venture backed medical device company. From 2005 to 2007, Mr. de Greef was Vice President and Chief Financial Officer of Cambridge Heart, Inc. Prior, Mr. de Greef was the Executive Vice President and Chief Financial Officer of Cardiac Science, Inc., from 2001 to 2005 when the Company merged with Quinton Cardiology. From 1995 to 2001, Mr. de Greef provided corporate finance advisory services to a number of early stage companies including Cardiac Science, where he was instrumental in securing equity capital beginning in 1997, and advising on merger and acquisition activity. Mr. de Greef has a B.A. in Economics and International Relations from California State University at San Francisco and an M.B.A. from the University of Oregon. In addition to serving on the board of directors of Tewksbury, MA based Cambridge Heart, Mr. de Greef also serves on the boards of Endologix, a public medical device company based in Irvine, CA, and BioLife Solutions, a public biotechnology company based in Bothell, WA. |